Cantel

FDAnews Announces Getting on the Right Side of the Digital Divide: Case Studies featuring Advanced Sterilization Products and Cantel Medical Webinar Sponsored by Axendia

Thursday, January 14, 2021 - 8:00pm

As part of the process, ASP recognized the opportunity to improve their business processes.

Key Points: 
  • As part of the process, ASP recognized the opportunity to improve their business processes.
  • Under J&J, ASP's quality management processes and capabilities were spread across multiple systems.
  • New research shows that innovative companies like Advanced Sterilization Products (ASP) and Cantel Medical are on the right side of this digital divide.
  • Getting on the Right Side of the Digital Divide:

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Cantel Medical Corp. Buyout

Thursday, January 14, 2021 - 12:30am

announces that it is investigating Cantel Medical Corp. (Cantel) (NYSE: CMD ) regarding possible breaches of fiduciary duties and other violations of law related to Cantels agreement to be acquired by STERIS plc (STERIS) (NYSE: STE ).

Key Points: 
  • announces that it is investigating Cantel Medical Corp. (Cantel) (NYSE: CMD ) regarding possible breaches of fiduciary duties and other violations of law related to Cantels agreement to be acquired by STERIS plc (STERIS) (NYSE: STE ).
  • Under the terms of the agreement, Cantels shareholders will receive approximately $16.93 in cash and 0.33787 of a share of STERIS per share.
  • To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-cantel-medical-corp .
  • You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or info@rl-legal.com .

CANTEL MEDICAL INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cantel Medical Corp - CMD

Thursday, January 14, 2021 - 12:27am

and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).

Key Points: 
  • and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Cantel Medical Corp (NYSE: CMD) to STERIS plc (NYSE: STE).
  • Under the terms of the proposed transaction, shareholders of Cantel will receive only $16.93 in cash and 0.33787 of a STERIS ordinary share for each share of Cantel that they own.
  • KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
  • To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com .

CANTEL ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of CMD and Encourages Investors to Contact the Firm

Tuesday, January 12, 2021 - 5:21pm

On January 12, 2021, Cantel announced that it had signed an agreement to be acquired by STERIS for approximately $4.6 billion.

Key Points: 
  • On January 12, 2021, Cantel announced that it had signed an agreement to be acquired by STERIS for approximately $4.6 billion.
  • Pursuant to the merger agreement, Cantel stockholders will receive $16.93 in cash and 0.33787 shares of STERIS common stock for each share of Cantel common stock owned.
  • The deal is scheduled to close by the end of STERISs first quarter of fiscal 2022 (ending June 30, 2021).
  • Bragar Eagel & Squire is concerned that Cantels board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.

Cantel Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Cantel Medical Corp. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – CMD

Tuesday, January 12, 2021 - 2:48pm

Under the terms of the merger agreement, Cantel shareholders will receive approximately $16.93 in cash and 0.33787 of a STERIS ordinary share per Cantel common share.

Key Points: 
  • Under the terms of the merger agreement, Cantel shareholders will receive approximately $16.93 in cash and 0.33787 of a STERIS ordinary share per Cantel common share.
  • On behalf of Cantel shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Censis Technologies and Cantel Medical Enter Into Partnership to Develop Differentiated Endoscope Reprocessing Software Solution

Monday, December 7, 2020 - 4:00pm

Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantels leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.

Key Points: 
  • Today, Censis Technologies, a wholly owned subsidiary of Fortive Corporation, and Cantel Medical Corp announced a new long-term partnership to combine Cantels leading infection prevention endoscope reprocessing workflow portfolio with the surgical asset management and instrument tracking solutions from Censis.
  • The new enhanced, co-branded software solution will combine the CANEXIS Integrated Workflow Solution for Endoscopy from Cantel with Censis CensiTrac surgical asset management software to create the leading instrument reprocessing and scope tracking software available to the market.
  • We are thrilled to be partnering with Censis on this critical endeavor, said Michael Spicer, President, Medical Business Unit at Cantel.
  • Censis Technologies, based in Franklin, Tennessee, is the leader in surgical instrument and asset management software.

Cantel Announces Senior Leadership Promotions in Dental

Thursday, December 3, 2020 - 2:00pm

LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021.

Key Points: 
  • LITTLE FALLS, N.J., Dec. 3, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) announced today the appointment of Andy Xilas to President, Cantel Dental effective January 1, 2021.
  • In addition, Jennifer Naylor has been appointed to the newly created role of Senior Vice President, Infection Prevention and Control Strategy and Education for Cantel.
  • Mr. Xilas and Ms. Naylor both joined Cantel in 2019, as part of Cantel's acquisition of Hu-Friedy and will sit on the Company's Executive Leadership Team.
  • He leaves in place a great leadership team capable of continuing the growth of Cantel Dental.

Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2020

Tuesday, November 24, 2020 - 12:00pm

LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.

Key Points: 
  • LITTLE FALLS, N.J., Nov. 24, 2020 /PRNewswire/ --CANTEL MEDICAL CORP. (NYSE:CMD) will release the results for its first quarter ended October 31, 2020 on Tuesday, December 8, 2020 before the market opens, and hold a conference call to discuss the results at 8:30 a.m.
  • To participate in the conference call, dial 1-844-602-0380 (US & Canada) or 1-862-298-0970 (International) approximately 5 to 10 minutes before the beginning of the call.
  • A replay of the presentation will be archived on the Cantel website for those unable to listen live.
  • In addition, the Company will provide a supplemental presentation to complement the conference call.

Cantel Hires Michael Drexel to SVP and Chief Technology Officer

Thursday, October 1, 2020 - 12:00pm

LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ --CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer.

Key Points: 
  • LITTLE FALLS, N.J., Oct. 1, 2020 /PRNewswire/ --CANTEL MEDICAL CORP (NYSE:CMD) announced today that Michael Drexel has been hired as Senior Vice President and Chief Technology Officer reporting to George Fotiades, Chief Executive Officer.
  • Mr. Drexel has extensive leadership in product development including driving continuous improvement and developing management, engineering and technical talent.
  • George Fotiades, Chief Executive Officershared, "We are excited to welcome Michael to Cantel, he has a proven track record of successfully leading technology teams in the drive for continuous improvement in product development through to product launch."
  • With more than 25 years of experience across various manufacturing sectors, including medical device, Mr. Drexel brings strong leadership and technical acumen to the role.

Avanos Medical, Inc. Appoints Michelle Scharfenberg as Senior Vice President & Chief Ethics and Compliance Officer

Tuesday, September 15, 2020 - 12:00pm

ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.

Key Points: 
  • ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michelle Scharfenberg has been named as the company's senior vice president & chief ethics and compliance officer.
  • In this role, Scharfenberg will be responsible for leading the Avanos Compliance & Ethics (C&E) program, which operationalizes Avanos's commitment to ethical and legally compliant operations.
  • Previously, Scharfenberg served as vice president and chief compliance officer for Cantel Medical Corporation, a leading provider of infection prevention products and services in the healthcare market.
  • "I am very pleased to have Michelle join Avanos in this role," stated Joe Woody, chief executive officer.